The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans

Human Immunology

Volumn 75, Issue 4, 2014, Pages 322-329

  Chávez Sánchez, Luis ^a   Garza Reyes, Montserrat Guadalupe ^a,b   Espinosa Luna, José Esteban ^a   Chávez Rueda, Karina ^a   Legorreta Haquet, María Victoria ^a   Blanco Favela, Francisco ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; FOAM CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; YOUNG ADULT;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD36; ANTIGENS, CD86; CELLS, CULTURED; CYTOKINES; FOAM CELLS; HEALTHY VOLUNTEERS; HLA-DR ANTIGENS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84895509356     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.01.012     Document Type: Article

References (35)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
2. Miller Y.I., Choi S.H., Wiesner P., Fang L., Harkewicz R., Hartvigsen K., et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 2011, 108:235-348.
3. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1135-1145.
4. Bannered A., Gerondakis S. Coordinating TLR-activated signaling pathways in cells of the immune system. Immunol Cell Biol 2007, 85:420-424.
5. Geng H., Wang A., Rong G., Zhu B., Deng Y., Chen J., et al. The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway. Mol Cell Biochem 2010, 342:201-206.
6. Chávez-Sánchez L., Madrid-Miller A., Chávez-Rueda K., Legorreta-Haquet M.V., Tesoro-Cruz E., Blanco-Favela F. Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response. Hum Immunol 2010, 71:737-744.
7. Janabi M., Yamashita S., Hirano K., Sakai N., Hiraoka H., Matsumoto K., et al. LDL Oxidized -induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol 2000, 20:1953-1960.
8. Fortun A., Khalil A., Gagné D., Douziech N., Kuntz C., Jay-Gerin J.P., et al. Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 2001, 156:11-21.
9. Zaguri R., Verbovetski I., Atallah M., Trahtemberg U., Krispin A., Nahari E., et al. 'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells. Clin Exp Immunol 2007, 149(3):543-552.
10. Mullick A.E., Tobias P.S., Curtiss L.K. Modulation of atherosclerosis in mice by toll-like receptor 2. J Clin Invest 2005, 115:3149-3156.
11. Michelsen K.S., Wong M.H., Shah P.K., Zhang W., Yano J., Doherty T.M., et al. Lack of toll-like receptor 4 or mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004, 101:10685-10690.
12. Choi S.H., Harkewicz R., Lee J.H., Boullier A., Almazan F., Li A.C., et al. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 2009, 104:1355-1363.
13. Liu X., Ukai T., Yumoto H., Davey M., Goswami S., Gibson F.C., et al. Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis 2008, 196:146-154.
14. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 2006, 4:211-221.
15. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000, 105:1049-1056.
16. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816.
17. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 2002, 277:49982-49988.
18. Moore K.J., Kunjathoor V.V., Koehn S.L., Manning J.J., Tseng A.A., Silver J.M., et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 2005, 115:2192-2201.
19. Zhao Z.Z., Wang Z., Li G.H., Wang R., Tan J.M., Cao X., et al. Hydrogen sulfide inhibits macrophage-derived foam cell formation. Exp Biol Med (Maywood) 2011, 236:169-176.
20. Higashimori M., Tatro J.B., Moore K.J., Mendelsohn M.E., Galper J.B., Beasley D. Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2011, 31:50-57.
21. Howell K.W., Meng X., Fullerton D.A., Jin C., Reece T.B., Cleveland J.C. Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells. J Surg Res 2011, 171:e27-e31.
22. Roelofs M.F., Boelens W.C., Joosten L.A., Abdollahi-Roodsaz S., Geurts J., Wunderink L.U., et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006, 176:7021-7027.
23. Chávez-Sánchez L., Chávez-Rueda K., Legorreta-Haquet M.V., Zenteno E., Ledesma-Soto Y., Montoya-Díaz E., et al. The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1b, IL-6, and IL-10 secretion in human monocytes and macrophages. Lipids Health Dis 2010, 9:117-124.
24. Pasini A.F., Anselmi M., Garbin U., Franchi E., Stranieri C., Nava M.C., et al. Enhanced levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via upregulation of CD14 and toll-like receptor 4 in unstable angina. Arterioscler Thromb Vasc Biol 2007, 27:1991-1997.
25. Sheedy F.J., Grebe A., Rayner K.J., Kalantari P., Ramkhelawon B., Carpenter S.B., et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 2013, 14:812-820.
26. Masternak K., Muhlethaler-Mottet A., Villard J., Zufferey M., Steimle V., et al. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev 2000, 14:1156-1166.
27. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002, 20:709-760.
28. Asai Y., Makimura Y., Ogawa T. Toll-like receptor 2-mediated dendritic cell activation by a Porphyromonas gingivalis synthetic lipopeptide. J Med Microbiol 2007, 56:459-465.
29. Hertz C.J., Kiertscher S.M., Godowski P.J., Bouis D.A., Norgard M.V., Roth M.D., et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol 2001, 166:2444-2450.
30. Broos S., Lundberg K., Akagi T., Kadowaki K., Akashi M., Greiff L., et al. Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: implications for specific immunotherapy. Vaccine 2010, 28:5075-5085.
31. Mills K.H. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011, 11:807-822.
32. Fuster J.J., Fernández P., González-Navarro H., Silvestre C., Nabah Y.N., Andrés V. Control of cell proliferation in atherosclerosis: insights from animal models and human studies. Cardiovasc Res 2010, 86:254-264.
33. McLaren J.E., Ramji D.P. Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 2009, 20:125-135.
34. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., et al. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
35. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., et al. CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010, 11:155-161.